ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 423025 | 3-year financial timeline | COVID resilience: 62/100
🛡️ Public data only — no PHI permitted on this instance.
$35M
Latest Revenue (FY2022)
+9.0%
Revenue CAGR (3yr)
17.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $30M | $30M | $35M | +17.8% | +9.0% |
| Operating Expenses | $24M | $25M | $29M | +17.5% | +9.1% |
| Operating Margin | 17.5% | 17.3% | 17.4% | +1.1% | -0.2% |
| Net Income | $5M | $5M | $6M | +19.1% | +8.8% |
| Licensed Beds | 96 | 96 | 96 | +0.0% | +0.0% |
| Total Patient Days | 21,314 | 21,199 | 23,341 | +10.1% | +4.6% |
| Medicare Day % | 65% | 65% | 67% | +2.5% | +1.1% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 62/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +18.8% ($30M → $35M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+9.0%
This Hospital
+7.6%
State Avg
Latest Margin
17.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $38M | 17.4% |
| FY2024 (proj) | $41M | 17.4% |
| FY2025 (proj) | $43M | 17.3% |